Asia Pacific Contrast Injector Systems Market (2018 - 2024)

Asia Pacific Contrast Injector Systems Market (2018 - 2024)

  • November 2018 •
  • 94 pages •
  • Report ID: 5336613 •
  • Format: PDF
The Asia Pacific Contrast Injector Systems Market would witness market growth of 9.1% CAGR during the forecast period (2018 – 2024). Contrast injector systems are medical devices which use contrast media to improve the visibility of complex body structures, namely body fluids, tissues, arteries, and veins. The diagnostic process is conducted using various imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography. Asia Pacific is an emerging market place in contrast injector market and it is likely to grow at a lucrative pace during the forecast period of time. The Asia Pacific contrast injector market is majorly contributed by China and India. India is anticipated to grow at a healthy pace during the forecast period of time. The contrast injector market is emphatically powered by the expanding range of annual diagnostic systems across all of the diagnostic imaging modalities. There are considerable technological advancements in contrast injector systems, which have resulted in availability of advanced treatment options for the management of chronic ailments. The demand for contrast injector devices is on a continuous growth due to rise in geriatric populace, susceptible to chronic illnesses and due to increased volume of diagnostic treatments globally.

Based on Application, the market is segmented into Geospatial Mapping, Disaster Management, Energy & Resource Management, Surveillance & Monitoring, and Others. Based on End User, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Angiodynamics Inc., GE Healthcare (A Healthcare Division of GE Company), Medtron AG, Nemoto Kyorindo Co., Ltd., Sino Medical- Device Technology Co., Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., Ulrich GmbH & Co. Kg, Vivid Imaging and Guerbet Group.